Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

India flag India · Delayed Price · Currency is INR
379.80
-3.15 (-0.82%)
May 9, 2025, 3:29 PM IST
54.39%
Market Cap 34.75B
Revenue (ttm) 13.37B
Net Income (ttm) 1.51B
Shares Out 91.67M
EPS (ttm) 16.49
PE Ratio 22.99
Forward PE n/a
Dividend 4.50 (1.18%)
Ex-Dividend Date Sep 13, 2024
Volume 125,368
Average Volume 166,484
Open 380.00
Previous Close 382.95
Day's Range 371.20 - 381.95
52-Week Range 211.30 - 572.00
Beta 0.72
RSI 41.34
Earnings Date May 21, 2025

About NSE:INDRAMEDCO

Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, ... [Read more]

Sector Healthcare
Founded 1983
Employees 2,977
Stock Exchange National Stock Exchange of India
Ticker Symbol INDRAMEDCO
Full Company Profile

Financial Performance

In 2023, NSE:INDRAMEDCO's revenue was 12.45 billion, an increase of 13.29% compared to the previous year's 10.99 billion. Earnings were 1.24 billion, an increase of 43.89%.

Financial Statements

News

There is no news available yet.